Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas Appoints Three Senior Development Heads | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Astellas Appoints Three Senior Development Heads

Fleishaker, Gronen, and Krivoshik to lead clinical, data, and oncology departments

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Astellas has made three senior-level promotions within its development organization. Joseph Fleishaker, Ph.D., FAAPS, FCP, was promoted to senior vice president and head of Clinical Pharmacology and Exploratory Development (CPED); Susanne Gronen was promoted to senior vice president and head of Data Sciences; and, Andrew Krivoshik, M.D., Ph.D., was promoted to vice president of Medical Science, Oncology. 
 
Dr. Fleishaker will report to Dr. Zeiher and will be responsible for providing leadership of the clinical pharmacology and early development work across the global development portfolio. Ms. Gronen will also report to Dr. Zeiher and provide global leadership of the Data Sciences function, which includes biostatistics, data management, medical writing, statistical programming, and systems management.

Dr. Krivoshik will report to Steven Benner, M.D., senior vice president and Therapeutic Area Head for Oncology. He will lead the medical group within Oncology, responsible for helping to advance Astellas’ oncology pipeline, which includes numerous clinical programs in areas such as prostate cancer, leukemia, lung cancer, bladder cancer, breast cancer, and gastroesophageal adenocarcinoma, among others.
 
“These promotions reinforce the strength of talent we have across the development organization at Astellas,” said Bernhardt G. Zeiher, M.D., president, Development, Astellas. “I couldn’t be more pleased that Joe, Susanne and Andrew will be leading critical parts of our global organization so we can deliver valuable medicines to patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics